
|Videos|December 16, 2022
Selecting Between Treatment With Cabazitaxel or Radiotherapy for Patients with mCRPC
Author(s)Neal Shore, MD, FACS
Dr Shore details how he approaches treatment selection between cabazitaxel and radiotherapy for patients with mCRPC.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
2
FDA approves sildenafil oral film for men with erectile dysfunction
3
Sarah Azari, MD, on early sexual health education for women with bladder cancer
4
URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues
5







